{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:08:44Z","timestamp":1770070124482,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04520-4","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:52:21Z","timestamp":1770029541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2621-7991","authenticated-orcid":false,"given":"Jingjia","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-7359","authenticated-orcid":false,"given":"Yaru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7201-3711","authenticated-orcid":false,"given":"Zihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4356-8212","authenticated-orcid":false,"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-756X","authenticated-orcid":false,"given":"Aiqiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8333-0883","authenticated-orcid":false,"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"4520_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024)","journal-title":"CA Cancer J. Clin."},{"key":"4520_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12020-024-04027-4","volume":"87","author":"P Malandrino","year":"2025","unstructured":"P. Malandrino, D. Tumino, M. Russo, Le R. Moli, A. Prinzi, T. Piticchio et al., Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence. Endocrine. 87, 658\u2013666 (2025)","journal-title":"Endocrine"},{"key":"4520_CR3","doi-asserted-by":"crossref","unstructured":"Y.-S. Lin, R.-F. Wang, R. Huang, Q. Wen, W. Cao, L.-B. Chen et al., Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition). Eur. J. Nucl. Med. Mol. Imaging 2025 . 52, 3859-3876 ( 2025)","DOI":"10.1007\/s00259-025-07222-1"},{"key":"4520_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"D.S. Chen, I. Mellman, Oncology Meets immunology: the cancer-immunity cycle. Immunity. 39, 1\u201310 (2013)","journal-title":"Immunity"},{"key":"4520_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"J.S. O\u2019Donnell, M.W.L. Teng, M.J. Smyth, Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167 (2019)","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"4520_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"J. Borst, T. Ahrends, N. B\u0105ba\u0142a, C.J.M. Melief, W. Kastenm\u00fcller, CD4\u2009+\u2009T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018)","journal-title":"Nat. Rev. Immunol."},{"key":"4520_CR7","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"F. Pag\u00e8s, B. Mlecnik, F. Marliot, G. Bindea, F.-S. Ou, C. Bifulco et al., International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 391, 2128\u20132139 (2018)","journal-title":"Lancet"},{"key":"4520_CR8","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1038\/bjc.2013.634","volume":"109","author":"AN Seo","year":"2013","unstructured":"A.N. Seo, H.J. Lee, E.J. Kim, H.J. Kim, M.H. Jang, H.E. Lee et al., Tumour-infiltrating CD8\u2009+\u2009lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br. J. Cancer. 109, 2705\u20132713 (2013)","journal-title":"Br. J. Cancer"},{"key":"4520_CR9","doi-asserted-by":"publisher","first-page":"10599","DOI":"10.2147\/JIR.S494342","volume":"17","author":"H Xiao","year":"2024","unstructured":"H. Xiao, P. Zhang, S. Zhang, H. Xiao, H. Zhou, D. Liu et al., Peripheral T lymphocyte predicts the prognosis of gastric cancer patients undergoing radical gastrectomy: A multicenter retrospective cohort study. J. Inflamm. Res. 17, 10599\u201310612 (2024)","journal-title":"J. Inflamm. Res."},{"key":"4520_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"R.M. Tuttle, S. Ahuja, A.M. Avram, V.J. Bernet, P. Bourguet, G.H. Daniels et al., Controversies, Consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: A joint statement from the American thyroid association, the European association of nuclear medicine, the society of nuclear medicine and molecular Imaging, and the European thyroid association. Thyroid. 29, 461\u2013470 (2019)","journal-title":"Thyroid"},{"key":"4520_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al., 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26, 1\u2013133 (2016)","journal-title":"Thyroid"},{"key":"4520_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.smim.2012.04.008","volume":"24","author":"R Solana","year":"2012","unstructured":"R. Solana, R. Tarazona, I. Gayoso, O. Lesur, G. Dupuis, T. Fulop, Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 24, 331\u2013341 (2012)","journal-title":"Semin Immunol."},{"key":"4520_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"S.L. Klein, K.L. Flanagan, Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016)","journal-title":"Nat. Rev. Immunol."},{"key":"4520_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","volume":"9","author":"MR Gubbels Bupp","year":"2018","unstructured":"M.R. Gubbels Bupp, T.N. Jorgensen, Androgen-Induced immunosuppression. Front. Immunol. 9, 794 (2018)","journal-title":"Front. Immunol."},{"key":"4520_CR15","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-13-0431","volume":"21","author":"LL Cunha","year":"2014","unstructured":"L.L. Cunha, M.A. Marcello, L.S. Ward, The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr. Relat. Cancer. 21, R85\u2013103 (2014)","journal-title":"Endocr. Relat. Cancer"},{"key":"4520_CR16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1210\/jc.2011-1838","volume":"97","author":"F Gogali","year":"2012","unstructured":"F. Gogali, G. Paterakis, G.Z. Rassidakis, G. Kaltsas, C.I. Liakou, P. Gousis et al., Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid. J. Clin. Endocrinol. Metab. 97, 1474\u20131482 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4520_CR17","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s40618-023-02072-w","volume":"46","author":"Y-Y Li","year":"2023","unstructured":"Y.-Y. Li, S.-J. Li, M.-C. Liu, Z. Chen, L. Li, F. Shen et al., B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer. J. Endocrinol. Invest. 46, 2247\u20132256 (2023)","journal-title":"J. Endocrinol. Invest."},{"key":"4520_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","volume":"619","author":"L Bod","year":"2023","unstructured":"L. Bod, Y.-C. Kye, J. Shi, E. Torlai Triglia, A. Schnell, J. Fessler et al., B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature. 619, 348\u2013356 (2023)","journal-title":"Nature"},{"key":"4520_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00432-023-05508-1","volume":"150","author":"H Zhang","year":"2024","unstructured":"H. Zhang, Y. Li, G. Liu, X. Chen, Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer. J. Cancer Res. Clin. Oncol. 150, 28 (2024)","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"4520_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/cen.12586","volume":"83","author":"LL Cunha","year":"2015","unstructured":"L.L. Cunha, M.A. Marcello, S. Nonogaki, E.C. Morari, F.A. Soares, J. Vassallo et al., CD8\u2009+\u2009tumour-infiltrating lymphocytes and COX2 expression May predict relapse in differentiated thyroid cancer. Clin. Endocrinol. (Oxf). 83, 246\u2013253 (2015)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4520_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"H.M. Knochelmann, C.J. Dwyer, S.R. Bailey, S.M. Amaya, D.M. Elston, J.M. Mazza-McCrann et al., When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell. Mol. Immunol. 15, 458\u2013469 (2018)","journal-title":"Cell. Mol. Immunol."},{"key":"4520_CR22","doi-asserted-by":"publisher","first-page":"894919","DOI":"10.3389\/fimmu.2022.894919","volume":"13","author":"Z Chen","year":"2022","unstructured":"Z. Chen, M.-L. Guo, Y.-Y. Li, K. Yan, L. Li, F. Shen et al., Immune profiling identifies CD8\u2009+\u2009T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer. Front. Immunol. 13, 894919 (2022)","journal-title":"Front. Immunol."},{"key":"4520_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5114\/ceji.2022.119171","volume":"47","author":"Y Hu","year":"2022","unstructured":"Y. Hu, X. Guo, H. Chen, Q. Chang, H. Lu, Y. Li et al., Constructing a thyroid cancer prognostic risk model based on CD8\u2009+\u2009T cell associated genes. Cent. Eur. J. Immunol. 47, 234\u2013245 (2022)","journal-title":"Cent. Eur. J. Immunol."},{"key":"4520_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13000-020-00931-1","volume":"15","author":"H Lu","year":"2020","unstructured":"H. Lu, L. Zhang, Y. Dai, Y. Ruan, X. Cao, X. Cai et al., Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma. Diagn. Pathol. 15, 16 (2020)","journal-title":"Diagn. Pathol."},{"key":"4520_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"A. Sarvaria, J.A. Madrigal, A. Saudemont, B cell regulation in cancer and anti-tumor immunity. Cell. Mol. Immunol. 14, 662\u2013674 (2017)","journal-title":"Cell. Mol. Immunol."},{"key":"4520_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00428-021-03137-y","volume":"479","author":"Z Yang","year":"2021","unstructured":"Z. Yang, L. Yin, Y. Zeng, Y. Li, H. Chen, S. Yin et al., Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma. Virchows Arch. 479, 947\u2013959 (2021)","journal-title":"Virchows Arch."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04520-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:52:24Z","timestamp":1770029544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04520-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04520-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Declaration of Helsinki. All of the study procedures were authorized by the institutional review board at the Second Hospital of Shandong University (KYLL-2022(LW)077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"53"}}